LYRA THERAPEUTICS, INC.

Company

Lyra Therapeutics, Inc.

Filed

November 16, 2023

Accession Number

0000902664-23-005625

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →